{ "x402Version": 2, "id": 39547, "slug": "39547", "resource": "https://api.magentlab.com/api/calc/nafcs", "description": "Hegele 2025 NAFCS. Table 3 points from age or early HTG onset, BMI, abdominal pain or pancreatitis, secondary factors, fasting TG >880 mg/dL or >10 mmol/L, TG/TC >8 (mg/dL) or >3.5 (mmol/L), and apo B <1.0 g/L, plus published interactions. Max 100. ≥60 definite classical FCS; ≥45 very likely. Not a diagnosis or genetic test. Not Simon Broome or Dutch FH. magent does not examine the patient or assay lipids. Not a medical device.", "type": "http", "serviceName": "magent", "resourceType": "Agent Service", "accepts": [ { "scheme": "exact", "network": "eip155:8453", "payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2", "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913", "amount": "5000", "amountUsd": 0.005, "maxTimeoutSeconds": 600 } ], "outputSchema": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" }, "extensions": { "bazaar": { "info": { "iconUrl": "https://api.magentlab.com/favicon.ico", "input": { "body": { "items": [ { "abdominal_history": "none", "age_years": 40, "apo_b_g_l": 1.2, "apo_b_mg_dl": 120, "bmi_below_threshold": false, "htg_onset_before_age_10": false, "secondary_factors_present": true, "tg_mg_dl": 500, "tg_mmol_l": 8, "tg_tc_ratio_mg_dl": 5, "tg_tc_ratio_mmol_l": 2 }, { "abdominal_history": "none", "age_years": 40, "apo_b_g_l": 1.2, "apo_b_mg_dl": 120, "bmi_below_threshold": false, "htg_onset_before_age_10": false, "secondary_factors_present": true, "tg_mg_dl": 500, "tg_mmol_l": 8, "tg_tc_ratio_mg_dl": 5, "tg_tc_ratio_mmol_l": 2 } ] }, "method": "POST", "type": "http" }, "output": { "example": { "count": 2, "items": [ { "age_years": 40, "all_tg_severely_elevated": false, "citation": { "authors": "Hegele RA, Ahmad Z, Ashraf A, et al.", "doi": "10.1016/j.jacl.2024.09.008", "id": "hegele-2025", "pmid": "39537503", "source": "J Clin Lipidol. 2025;19(1):83-94", "title": "Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America" }, "components": [ { "factor": "early_htg_onset", "points": 0, "present": false }, { "factor": "child_htg", "points": 0, "present": false }, { "factor": "all_tg_severely_elevated", "points": 0, "present": false }, { "factor": "high_tg_tc_ratio", "points": 0, "present": false }, { "factor": "low_apo_b", "points": 0, "present": false }, { "factor": "bmi_below_threshold", "points": 0, "present": false }, { "factor": "abdominal_pain", "points": 0, "present": false }, { "factor": "pancreatitis", "points": 0, "present": false }, { "factor": "no_secondary_factors", "points": 0, "present": false }, { "factor": "high_ratio_and_low_apo_b", "points": 0, "present": false }, { "factor": "child_and_no_secondary", "points": 0, "present": false }, { "factor": "high_ratio_and_no_secondary", "points": 0, "present": false } ], "definite_classical_fcs": false, "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "nafcs", "formula_expression": "NAFCS = early_htg_onset 12 (age_years ≥10 and htg_onset_before_age_10) + child_htg 12 (age_years 1-9) + all_tg_severely_elevated 13 (all fasting TG >880 mg/dL or >10 mmol/L) + high_tg_tc_ratio 8 (TG/TC >8 mg/dL or >3.5 mmol/L) + low_apo_b 12 (apo B <1.0 g/L or <100 mg/dL) + bmi_below_threshold 9 (BMI <25 kg/m2 or <85th percentile) + abdominal_pain 9 (recurrent abdominal pain without pancreatitis) + pancreatitis 16 + no_secondary_factors 11 + high_ratio_and_low_apo_b 7 + child_and_no_secondary 7 + high_ratio_and_no_secondary 5 (Hegele 2025 Table 3, parameter estimates ×10); max 100; ≥60 definite classical FCS; ≥45 very likely classical FCS", "high_tg_tc_ratio": false, "low_apo_b": false, "max_score": 100, "score": 0, "very_likely_classical_fcs": false }, { "age_years": 40, "all_tg_severely_elevated": false, "citation": { "authors": "Hegele RA, Ahmad Z, Ashraf A, et al.", "doi": "10.1016/j.jacl.2024.09.008", "id": "hegele-2025", "pmid": "39537503", "source": "J Clin Lipidol. 2025;19(1):83-94", "title": "Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America" }, "components": [ { "factor": "early_htg_onset", "points": 0, "present": false }, { "factor": "child_htg", "points": 0, "present": false }, { "factor": "all_tg_severely_elevated", "points": 0, "present": false }, { "factor": "high_tg_tc_ratio", "points": 0, "present": false }, { "factor": "low_apo_b", "points": 0, "present": false }, { "factor": "bmi_below_threshold", "points": 0, "present": false }, { "factor": "abdominal_pain", "points": 0, "present": false }, { "factor": "pancreatitis", "points": 0, "present": false }, { "factor": "no_secondary_factors", "points": 0, "present": false }, { "factor": "high_ratio_and_low_apo_b", "points": 0, "present": false }, { "factor": "child_and_no_secondary", "points": 0, "present": false }, { "factor": "high_ratio_and_no_secondary", "points": 0, "present": false } ], "definite_classical_fcs": false, "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "nafcs", "formula_expression": "NAFCS = early_htg_onset 12 (age_years ≥10 and htg_onset_before_age_10) + child_htg 12 (age_years 1-9) + all_tg_severely_elevated 13 (all fasting TG >880 mg/dL or >10 mmol/L) + high_tg_tc_ratio 8 (TG/TC >8 mg/dL or >3.5 mmol/L) + low_apo_b 12 (apo B <1.0 g/L or <100 mg/dL) + bmi_below_threshold 9 (BMI <25 kg/m2 or <85th percentile) + abdominal_pain 9 (recurrent abdominal pain without pancreatitis) + pancreatitis 16 + no_secondary_factors 11 + high_ratio_and_low_apo_b 7 + child_and_no_secondary 7 + high_ratio_and_no_secondary 5 (Hegele 2025 Table 3, parameter estimates ×10); max 100; ≥60 definite classical FCS; ≥45 very likely classical FCS", "high_tg_tc_ratio": false, "low_apo_b": false, "max_score": 100, "score": 0, "very_likely_classical_fcs": false } ], "path": "/api/calc/nafcs" }, "type": "json" } }, "schema": { "$schema": "https://json-schema.org/draft/2020-12/schema", "properties": { "input": { "additionalProperties": false, "properties": { "body": { "additionalProperties": false, "properties": { "items": { "items": { "properties": { "abdominal_history": { "description": "Caller-assigned chylomicronemia-related abdominal history (Hegele 2025 Table 3): none (0), abdominal_pain = recurrent abdominal pain without pancreatitis (9), pancreatitis = history of pancreatitis with or without abdominal pain (16). magent does not diagnose pancreatitis.", "enum": [ "none", "abdominal_pain", "pancreatitis" ], "type": "string" }, "age_years": { "description": "Current age in whole years (1-120). Hegele 2025 Table 3: ages 1-9 score child_htg 12; ages ≥10 score early_htg_onset 12 only when htg_onset_before_age_10 is true. The score does not provide a value for infants <1 year. magent does not examine the patient.", "type": "integer" }, "apo_b_g_l": { "description": "Apolipoprotein B in g/L (0.1-3.0). <1.0 scores 12 (Hegele 2025 Table 3). Provide exactly one of apo_b_g_l or apo_b_mg_dl. 1.0 g/L = 100 mg/dL in the paper. magent does not assay apo B.", "type": "number" }, "apo_b_mg_dl": { "description": "Apolipoprotein B in mg/dL (10-300). <100 scores 12. Provide exactly one of apo_b_g_l or apo_b_mg_dl. magent does not assay apo B.", "type": "number" }, "bmi_below_threshold": { "description": "BMI <25.0 kg/m2 in adults or <85th percentile in children/adolescents as assigned by the caller (Hegele 2025 Table 3, 9 points). true or false. magent does not compute BMI or pediatric percentiles.", "type": "boolean" }, "htg_onset_before_age_10": { "description": "Hypertriglyceridemia onset in infancy or childhood (before age 10) as assigned by the caller (Hegele 2025 Table 1). true or false. Scores 12 only when age_years ≥10. For ages 1-9, child_htg is scored from age and this flag does not add points. magent does not date onset.", "type": "boolean" }, "secondary_factors_present": { "description": "One or more secondary factors that may contribute to hypertriglyceridemia as assigned by the caller (Hegele 2025 Table 1: lifestyle, medications, clinical conditions). true (≥1, 0 points) or false (none, 11 points, plus published interactions). magent does not take a history.", "type": "boolean" }, "tg_mg_dl": { "description": "Caller-assigned fasting triglycerides in mg/dL (440-20000) representing all readings used in the score (Hegele 2025 Table 1: last 3 labs in adults, last 2 in children). All readings >880 score 13. Provide exactly one of tg_mg_dl or tg_mmol_l. magent does not assay lipids.", "type": "number" }, "tg_mmol_l": { "description": "Caller-assigned fasting triglycerides in mmol/L (5-226). All readings >10 score 13. Provide exactly one of tg_mg_dl or tg_mmol_l. magent does not assay lipids.", "type": "number" }, "tg_tc_ratio_mg_dl": { "description": "Triglyceride/total-cholesterol ratio when both are in mg/dL (0.1-80). >8 scores 8 (Hegele 2025 Table 1). Provide exactly one of tg_tc_ratio_mg_dl or tg_tc_ratio_mmol_l. magent does not assay lipids.", "type": "number" }, "tg_tc_ratio_mmol_l": { "description": "Triglyceride/total-cholesterol ratio when both are in mmol/L (0.1-35). >3.5 scores 8. Provide exactly one of tg_tc_ratio_mg_dl or tg_tc_ratio_mmol_l. magent does not assay lipids.", "type": "number" } }, "required": [ "age_years", "htg_onset_before_age_10", "bmi_below_threshold", "abdominal_history", "secondary_factors_present" ], "type": "object" }, "maxItems": 25, "minItems": 1, "type": "array" } }, "required": [ "items" ], "type": "object" }, "headers": { "additionalProperties": { "type": "string" }, "type": "object" }, "method": { "const": "POST", "type": "string" }, "type": { "const": "http", "type": "string" } }, "required": [ "type", "method" ], "type": "object" }, "output": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" } }, "required": [ "input" ], "type": "object" } } }, "tags": [ "nafcs", "fcs", "lipids", "chylomicronemia", "hegele-2025", "bazaar" ], "sourceHost": "api.magentlab.com", "lastUpdated": "2026-10-12T14:08:35.749Z", "quality": { "calls30d": 3, "uniquePayers30d": 1, "lastCalledAt": "2026-10-12T14:08:35.609Z" }, "metadata": { "serviceName": "magent", "extensions": { "bazaar": { "info": { "iconUrl": "https://api.magentlab.com/favicon.ico", "input": { "body": { "items": [ { "abdominal_history": "none", "age_years": 40, "apo_b_g_l": 1.2, "apo_b_mg_dl": 120, "bmi_below_threshold": false, "htg_onset_before_age_10": false, "secondary_factors_present": true, "tg_mg_dl": 500, "tg_mmol_l": 8, "tg_tc_ratio_mg_dl": 5, "tg_tc_ratio_mmol_l": 2 }, { "abdominal_history": "none", "age_years": 40, "apo_b_g_l": 1.2, "apo_b_mg_dl": 120, "bmi_below_threshold": false, "htg_onset_before_age_10": false, "secondary_factors_present": true, "tg_mg_dl": 500, "tg_mmol_l": 8, "tg_tc_ratio_mg_dl": 5, "tg_tc_ratio_mmol_l": 2 } ] }, "method": "POST", "type": "http" }, "output": { "example": { "count": 2, "items": [ { "age_years": 40, "all_tg_severely_elevated": false, "citation": { "authors": "Hegele RA, Ahmad Z, Ashraf A, et al.", "doi": "10.1016/j.jacl.2024.09.008", "id": "hegele-2025", "pmid": "39537503", "source": "J Clin Lipidol. 2025;19(1):83-94", "title": "Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America" }, "components": [ { "factor": "early_htg_onset", "points": 0, "present": false }, { "factor": "child_htg", "points": 0, "present": false }, { "factor": "all_tg_severely_elevated", "points": 0, "present": false }, { "factor": "high_tg_tc_ratio", "points": 0, "present": false }, { "factor": "low_apo_b", "points": 0, "present": false }, { "factor": "bmi_below_threshold", "points": 0, "present": false }, { "factor": "abdominal_pain", "points": 0, "present": false }, { "factor": "pancreatitis", "points": 0, "present": false }, { "factor": "no_secondary_factors", "points": 0, "present": false }, { "factor": "high_ratio_and_low_apo_b", "points": 0, "present": false }, { "factor": "child_and_no_secondary", "points": 0, "present": false }, { "factor": "high_ratio_and_no_secondary", "points": 0, "present": false } ], "definite_classical_fcs": false, "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "nafcs", "formula_expression": "NAFCS = early_htg_onset 12 (age_years ≥10 and htg_onset_before_age_10) + child_htg 12 (age_years 1-9) + all_tg_severely_elevated 13 (all fasting TG >880 mg/dL or >10 mmol/L) + high_tg_tc_ratio 8 (TG/TC >8 mg/dL or >3.5 mmol/L) + low_apo_b 12 (apo B <1.0 g/L or <100 mg/dL) + bmi_below_threshold 9 (BMI <25 kg/m2 or <85th percentile) + abdominal_pain 9 (recurrent abdominal pain without pancreatitis) + pancreatitis 16 + no_secondary_factors 11 + high_ratio_and_low_apo_b 7 + child_and_no_secondary 7 + high_ratio_and_no_secondary 5 (Hegele 2025 Table 3, parameter estimates ×10); max 100; ≥60 definite classical FCS; ≥45 very likely classical FCS", "high_tg_tc_ratio": false, "low_apo_b": false, "max_score": 100, "score": 0, "very_likely_classical_fcs": false }, { "age_years": 40, "all_tg_severely_elevated": false, "citation": { "authors": "Hegele RA, Ahmad Z, Ashraf A, et al.", "doi": "10.1016/j.jacl.2024.09.008", "id": "hegele-2025", "pmid": "39537503", "source": "J Clin Lipidol. 2025;19(1):83-94", "title": "Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America" }, "components": [ { "factor": "early_htg_onset", "points": 0, "present": false }, { "factor": "child_htg", "points": 0, "present": false }, { "factor": "all_tg_severely_elevated", "points": 0, "present": false }, { "factor": "high_tg_tc_ratio", "points": 0, "present": false }, { "factor": "low_apo_b", "points": 0, "present": false }, { "factor": "bmi_below_threshold", "points": 0, "present": false }, { "factor": "abdominal_pain", "points": 0, "present": false }, { "factor": "pancreatitis", "points": 0, "present": false }, { "factor": "no_secondary_factors", "points": 0, "present": false }, { "factor": "high_ratio_and_low_apo_b", "points": 0, "present": false }, { "factor": "child_and_no_secondary", "points": 0, "present": false }, { "factor": "high_ratio_and_no_secondary", "points": 0, "present": false } ], "definite_classical_fcs": false, "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "nafcs", "formula_expression": "NAFCS = early_htg_onset 12 (age_years ≥10 and htg_onset_before_age_10) + child_htg 12 (age_years 1-9) + all_tg_severely_elevated 13 (all fasting TG >880 mg/dL or >10 mmol/L) + high_tg_tc_ratio 8 (TG/TC >8 mg/dL or >3.5 mmol/L) + low_apo_b 12 (apo B <1.0 g/L or <100 mg/dL) + bmi_below_threshold 9 (BMI <25 kg/m2 or <85th percentile) + abdominal_pain 9 (recurrent abdominal pain without pancreatitis) + pancreatitis 16 + no_secondary_factors 11 + high_ratio_and_low_apo_b 7 + child_and_no_secondary 7 + high_ratio_and_no_secondary 5 (Hegele 2025 Table 3, parameter estimates ×10); max 100; ≥60 definite classical FCS; ≥45 very likely classical FCS", "high_tg_tc_ratio": false, "low_apo_b": false, "max_score": 100, "score": 0, "very_likely_classical_fcs": false } ], "path": "/api/calc/nafcs" }, "type": "json" } }, "schema": { "$schema": "https://json-schema.org/draft/2020-12/schema", "properties": { "input": { "additionalProperties": false, "properties": { "body": { "additionalProperties": false, "properties": { "items": { "items": { "properties": { "abdominal_history": { "description": "Caller-assigned chylomicronemia-related abdominal history (Hegele 2025 Table 3): none (0), abdominal_pain = recurrent abdominal pain without pancreatitis (9), pancreatitis = history of pancreatitis with or without abdominal pain (16). magent does not diagnose pancreatitis.", "enum": [ "none", "abdominal_pain", "pancreatitis" ], "type": "string" }, "age_years": { "description": "Current age in whole years (1-120). Hegele 2025 Table 3: ages 1-9 score child_htg 12; ages ≥10 score early_htg_onset 12 only when htg_onset_before_age_10 is true. The score does not provide a value for infants <1 year. magent does not examine the patient.", "type": "integer" }, "apo_b_g_l": { "description": "Apolipoprotein B in g/L (0.1-3.0). <1.0 scores 12 (Hegele 2025 Table 3). Provide exactly one of apo_b_g_l or apo_b_mg_dl. 1.0 g/L = 100 mg/dL in the paper. magent does not assay apo B.", "type": "number" }, "apo_b_mg_dl": { "description": "Apolipoprotein B in mg/dL (10-300). <100 scores 12. Provide exactly one of apo_b_g_l or apo_b_mg_dl. magent does not assay apo B.", "type": "number" }, "bmi_below_threshold": { "description": "BMI <25.0 kg/m2 in adults or <85th percentile in children/adolescents as assigned by the caller (Hegele 2025 Table 3, 9 points). true or false. magent does not compute BMI or pediatric percentiles.", "type": "boolean" }, "htg_onset_before_age_10": { "description": "Hypertriglyceridemia onset in infancy or childhood (before age 10) as assigned by the caller (Hegele 2025 Table 1). true or false. Scores 12 only when age_years ≥10. For ages 1-9, child_htg is scored from age and this flag does not add points. magent does not date onset.", "type": "boolean" }, "secondary_factors_present": { "description": "One or more secondary factors that may contribute to hypertriglyceridemia as assigned by the caller (Hegele 2025 Table 1: lifestyle, medications, clinical conditions). true (≥1, 0 points) or false (none, 11 points, plus published interactions). magent does not take a history.", "type": "boolean" }, "tg_mg_dl": { "description": "Caller-assigned fasting triglycerides in mg/dL (440-20000) representing all readings used in the score (Hegele 2025 Table 1: last 3 labs in adults, last 2 in children). All readings >880 score 13. Provide exactly one of tg_mg_dl or tg_mmol_l. magent does not assay lipids.", "type": "number" }, "tg_mmol_l": { "description": "Caller-assigned fasting triglycerides in mmol/L (5-226). All readings >10 score 13. Provide exactly one of tg_mg_dl or tg_mmol_l. magent does not assay lipids.", "type": "number" }, "tg_tc_ratio_mg_dl": { "description": "Triglyceride/total-cholesterol ratio when both are in mg/dL (0.1-80). >8 scores 8 (Hegele 2025 Table 1). Provide exactly one of tg_tc_ratio_mg_dl or tg_tc_ratio_mmol_l. magent does not assay lipids.", "type": "number" }, "tg_tc_ratio_mmol_l": { "description": "Triglyceride/total-cholesterol ratio when both are in mmol/L (0.1-35). >3.5 scores 8. Provide exactly one of tg_tc_ratio_mg_dl or tg_tc_ratio_mmol_l. magent does not assay lipids.", "type": "number" } }, "required": [ "age_years", "htg_onset_before_age_10", "bmi_below_threshold", "abdominal_history", "secondary_factors_present" ], "type": "object" }, "maxItems": 25, "minItems": 1, "type": "array" } }, "required": [ "items" ], "type": "object" }, "headers": { "additionalProperties": { "type": "string" }, "type": "object" }, "method": { "const": "POST", "type": "string" }, "type": { "const": "http", "type": "string" } }, "required": [ "type", "method" ], "type": "object" }, "output": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" } }, "required": [ "input" ], "type": "object" } } } }, "liveness": { "reliability": null }, "verified": false, "featured": false, "provider": { "host": "api.magentlab.com", "manifest_name": "api.magentlab.com", "source": "cdp-mirror", "source_manifest_url": "https://api.cdp.coinbase.com/platform/v2/x402/discovery/resources", "submitted_at": "2026-10-14T01:15:01.050Z" }, "exampleResponse": { "example": {}, "type": "string" } }